Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

 

Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
Avatar

UPenn Expert Discussion on MDS, MPN & Leukemia: Transfusion-Dependent MDS Patients, Patients Treated With Hydroxyurea for MPN, AML Pts to Treat With Ven + HMAs, Oral HMAs, Maintenance Azacitidine

By Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient FEATURING Keith Pratz, Shannon McCurdy, Daria V. Babushok, Alexander Perl, Selina Luger, Sunil Saroha
By Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient FEATURING Keith Pratz, Shannon McCurdy, Daria V. Babushok, Alexander Perl, Selina Luger, Sunil Saroha
0 views
March 3, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

08:18
Insights from 2023 ASH Annual Meeting

Treatment Strategies for Hematocrit Control in PV

Feat. A. Zhou

Featured Video

24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
Update on Patient Care Treatment Strategies in Leukemia
12:45
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

Anti-CD19 CAR-T for R/R CLL: How Frequent Are MRD- Responses? When D…

Feat. D. Porter
13:58
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

Penn Medicine Updates on Blood/Marrow Transplantation & Cellular…

Feat. P. Ford
22:10
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

UPenn Expert Discussion on MDS, MPN & Leukemia: Transfusion-Depe…

Feat. K. Pratz, S. McCurdy, D. Babushok, A. Perl, S. Luger, S. Saroha
18:36
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

2021 Penn Update on AML: How Beneficial Is Ven Addition to Aza in El…

Feat. A. Perl
21:53
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

2021 Penn Medicine Update on FLT3i in R/R AML: Gilteritinib Mono and…

Feat. A. Perl
14:03
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

Penn Update on MPNs: Can We Prevent MPNs? Is RopegIFN Effective and …

Feat. D. Babushok
11:43
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

Penn Update on MPNs: Does PTG-300 Eliminate the Need for Therapeutic…

Feat. D. Babushok
14:31
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

Penn Updates on CML: Do Cancer-Related Mutational Events at Diagnosi…

Feat. D. Babushok
11:19
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

Penn Update on Lower Risk MDS: How Beneficial Are Lenalidomide, Lusp…

Feat. S. McCurdy
20:56
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

Penn Update on Novel Therapies for Higher Risk MDS: What Is the Role…

Feat. S. McCurdy